Stockscreener 앱 받기
36.27
1.95%
0.695
시간 외 거래:
36.28
0.005
+0.01%
전일 마감가:
$35.58
열려 있는:
$35.58
하루 거래량:
152.37K
Relative Volume:
0.67
시가총액:
$718.91M
수익:
$66.98M
순이익/손실:
$9.65M
주가수익비율:
75.57
EPS:
0.48
순현금흐름:
$10.19M
1주 성능:
+5.70%
1개월 성능:
+19.36%
6개월 성능:
-0.70%
1년 성능:
-5.88%
1일 변동 폭
$35.35
$36.33
1주일 범위
$33.09
$36.62
52주 변동 폭
$24.00
$51.22
Simulations Plus Inc Stock (SLP) Company Profile
명칭
Simulations Plus Inc
전화
661-723-7723
주소
800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA
SLP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLP
Simulations Plus Inc
|
36.27 | 718.91M | 66.98M | 9.65M | 10.19M | 0.48 |
|
VEEV
Veeva Systems Inc
|
237.20 | 38.43B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
79.23 | 14.73B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
73.38 | 12.59B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
68.96 | 10.57B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
111.52 | 9.69B | 1.15B | 96.70M | -161.99M | 1.09 |
Simulations Plus Inc Stock (SLP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-15 | 개시 | Stephens | Overweight |
| 2024-07-29 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-07-16 | 개시 | JMP Securities | Mkt Perform |
| 2024-06-28 | 개시 | William Blair | Outperform |
| 2023-05-09 | 개시 | BTIG Research | Buy |
| 2021-10-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2021-01-12 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2020-10-16 | 개시 | Raymond James | Outperform |
| 2020-09-08 | 개시 | Oppenheimer | Outperform |
| 2020-01-06 | 개시 | Craig Hallum | Buy |
모두보기
Simulations Plus Inc 주식(SLP)의 최신 뉴스
Conestoga Capital Advisors LLC Purchases 290,414 Shares of Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Short Interest Up 29.1% in January - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz Sells 20,000 Shares - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Given Average Rating of "Buy" by Analysts - MarketBeat
Insider Sell: Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc (SLP) - GuruFocus.com
Simulations Plus to Participate in Upcoming Healthcare Investor Conferences - BioSpace
Biotech Leader Simulations Plus Sets Stage for Major Investor Showcase at Premier Healthcare Conferences - StockTitan
William Blair Issues Pessimistic Outlook for SLP Earnings - MarketBeat
Q1 EPS Estimates for Simulations Plus Cut by William Blair - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Recommendation of “Buy” from Analysts - Defense World
SG Americas Securities LLC Has $698,000 Stock Holdings in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World
William Blair Issues Pessimistic Estimate for SLP Earnings - Defense World
KeyCorp Forecasts Strong Price Appreciation for Simulations Plus (NASDAQ:SLP) Stock - Defense World
Simulations Plus (NASDAQ:SLP) Price Target Raised to $37.00 - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by Tributary Capital Management LLC - MarketBeat
JPMorgan Chase & Co. Boosts Stake in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World
Simulations Plus, Inc. and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus®? Enhancements - Marketscreener.com
Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements - Business Wire
Simulations Plus (SLP) to Report Q2 Earnings: What's in Store? - MSN
World Bank warns that US tariffs could reduce global growth outlook -January 16, 2025 at 01:03 pm EST - Marketscreener.com
There May Be Reason For Hope In Simulations Plus' (NASDAQ:SLP) Disappointing Earnings - Yahoo Finance
Simulations Plus Inc (SLP) Stock Price Down 3.84% on Jan 14 - GuruFocus.com
Barclays PLC Has $911,000 Holdings in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World
Barclays PLC Grows Stock Holdings in Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024 - Business Wire
US Growth Companies With High Insider Ownership In January 2025 - Simply Wall St
Simulations Plus Powers 100% of FDA-Approved Drugs in 2024 with AI-Driven Solutions - StockTitan
Simulations Plus' Q1 Earnings Lag Estimates, Revenues Surge Y/Y - MSN
William Blair Has Pessimistic Outlook of SLP Q2 Earnings - Defense World
Conestoga Capital Advisors, LLC Expands Stake in Simulations Plu - GuruFocus.com
William Blair Issues Pessimistic Forecast for SLP Earnings - MarketBeat
KeyCorp Has Lowered Expectations for Simulations Plus (NASDAQ:SLP) Stock Price - Defense World
William Blair Issues Optimistic Outlook for SLP Earnings - Defense World
Simulations Plus, Inc. (NASDAQ:SLP) Receives $51.40 Average Price Target from Brokerages - Defense World
Simulations Plus First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Simulations Plus's SWOT analysis: bio-simulation leader faces growth challenges - Investing.com
Simulations Plus (NASDAQ:SLP) Price Target Cut to $35.00 by Analysts at KeyCorp - MarketBeat
Simulations Plus Inc (NASDAQ:SLP) Lags Earning Estimates - FXDailyReport.com
Simulations Plus (NASDAQ:SLP) Sets New 12-Month LowTime to Sell? - MarketBeat
Simulations Plus' (SLP) "Outperform" Rating Reaffirmed at William Blair - MarketBeat
Simulations Plus stock affirmed at Outperform on Q1 report By Investing.com - Investing.com Canada
Simulations Plus Inc. (SLP) reports earnings - Quartz
Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal - Simply Wall St
Simulations Plus Inc (SLP) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... By GuruFocus - Investing.com Canada
Simulations Plus: Fiscal Q1 Earnings Snapshot - mySA
Simulations Plus earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Simulations Plus Inc (SLP) Q1 2025 Earnings Call Highlights: Str - GuruFocus.com
Simulations Plus Inc (SLP) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
Simulations Plus Inc (SLP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Simulations Plus Inc 주식 (SLP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| WOLTOSZ WALTER S | Director |
Jan 02 '25 |
Sale |
27.88 |
20,000 |
557,662 |
3,422,584 |
0.00%
0.84%
자본화:
|
볼륨(24시간):